Schwab's Sonders: For the market's sake, Fed's medicine is best taken now

Liz Ann Sonders, chief investment strategist for Charles Schwab and Co. says that investors should be hoping that the medicine necessary to help a weaker economy reduce the inflationary fever would be best taken sooner than later, leading to 'a much more meaningful deterioration of the economy ... that sets up a Fed pause.' With that in mind, Sonders expects more short-term market pain, setting up a recovery and better opportunities beyond that. David Trainer of New Constructs puts Digital Realty Trust back into the Danger Zone this week, noting that while the stock is already down significantly, it could drop another 75 percent before he thinks the market price will reflect the company's true value. Plus, Vivian Tsai, chairman of the College Savings Foundation discusses programs for gifting future college tuition monies for the holidays, and Bryan Armour, director of passive strategies research at Morningstar, makes his debut in the Market Call talking investments in exchange-traded funds.